Home | Non-food

Non-food

Wireless at home could mean privacy-less

Contact: Christoph Sorgechristoph.sorge@uni-saarland.de49-068-130-25122Saarland University  Wireless home automation systems reveal more than you would think about user behavior This news release is available in German.  IMAGE: Home automation systems that control

Anti-pain agent shrinks oral cancers, leaves healthy tissues alone

Contact: Will Sansomsansom@uthscsa.edu210-567-2579University of Texas Health Science Center at San Antonio  Anti-pain agent shrinks oral cancers, leaves healthy tissues alone SAN ANTONIO (July 22, 2014) — Mouse ...
Full story

Statin use decreases the risk of Barrett's esophagus

Contact: Rachel Steigerwaldmedia@gastro.org301-272-1603American Gastroenterological Association  Statin use decreases the risk of Barrett's esophagus Bethesda, MD (July 23, 2014) — Statins, a class of drugs commonly used to ...
Full story

Sleep deprivation can cause false memories

Thursday July 24, 2014 (foodconsumer.org) -- Criminal defense lawyers be aware:  You may challenge eyewitnesses who testify against your client for the reliability of their ...
Full story

Dream On Me Recalls High Chairs Recalled

-----------NEWS from CPSC----------- U.S. Consumer Product Safety Commission Office of Communications 4330 East West Highway, Bethesda, MD 20814 www.cpsc.gov 1 Dream On Me Recalls High Chairs Due to Strangulation and ...
Full story

Produce Industry Committed to Helping Schools Meet Fruit and Vegetable Standards

News Release For Immediate Release, July 23, 2014 Contact: Ray Gilmer rgilmer@unitedfresh.org 202-303-3407 Produce Industry Committed to Helping Schools Meet Fruit and Vegetable Standards Past United Fresh Board Member Phil Muir Testifies Before ...
Full story

REBEL Platinum Chromium Coronary Stent System

REBEL Platinum Chromium Coronary Stent System (Monorail and Over-the-Wire) - P130030 This is a brief overview of information related to FDA’s approval to market this product. ...
Full story

FDA approves Zydelig (idelalisib) to treat blood cancers - news release

FDA News Release FDA approves Zydelig for three types of blood cancers For Immediate Release July 23, 2014 Release The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to ...
Full story

FDA approves Idelalisib for treatment of relapsed chronic lymphocytic leukemia

U.S. Food and Drug Administration (FDA) approved idelalisib (Zydelig tablets, Gilead Sciences, Inc.) for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, for whom rituximab alone would be considered appropriate therapy due to other co-morbidities. July 23, 2014. More Information...
Full story

Supreme Pharmaceuticals (CSE:SL) Evaluating Medical Cannabis Opportunities in Arizona - Video News Alert on Investmentpitch.com

Vancouver, BC, July 23, 2014 - Supreme Pharmaceuticals (CSE:SL) is in the preliminary stages of evaluating medical cannabis investment opportunities within the State of Arizona. These opportunities ...
Full story
back 1 2 3 4 5 6 7 8 9 10 next last total: 4531 | displaying: 51 - 60